Burgundy Asset Management Ltd. Merck & Co., Inc. Transaction History

Burgundy Asset Management Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $215,360 - $298,500	-3,399 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $26,222 - $29,588	-338 Reduced 9.04%	3,399 $309,000
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $15,216 - $16,586	-200 Reduced 5.08%	3,737 $315,000
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $3,561 - $4,161	-51 Reduced 1.28%	3,937 $330,000
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $9,045 - $10,316	-130 Reduced 3.16%	3,988 $332,000
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $38,361 - $44,517	-588 Reduced 12.49%	4,118 $315,000
Q4 2017 Feb 12, 2018	SELL	$51.62 - $61.64 $6,865 - $8,198	-133 Reduced 2.75%	4,706 $0
Q3 2017 Nov 24, 2017	BUY	$58.67 - $63.13 $283,904 - $305,486	4,839 New	4,839 $310,000
Q3 2017 Nov 13, 2017	SELL	$58.67 - $63.13 $283,904 - $305,486	-4,839 Closed	0 $0
Q2 2017 Sep 15, 2017	BUY	N/A	4,839	4,839 $310,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Burgundy Asset Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Burgundy Asset Management Ltd. with notifications on news.